Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.14148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Heleen M A Hendriksen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Cognitive Dysfunction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health∼Holland, Topsector Life Sciences & Health, Horizon Europe IHI project PROMINENT, ZonMw.
Abstract (Originalsprache)
INTRODUCTION We disclosed amyloid positron emission tomography (PET) results in individuals with subjective cognitive decline (SCD) and studied patient experiences and outcomes over a 6‐month period. METHODS Fifty‐seven participants from the Subjective Cognitive Impairment Cohort (SCIENCe) (66 ± 8 years, 21 [37%] F, Mini‐Mental State Examination 29 ± 1, 15 [26%] amyloid positive [A+]) completed questionnaires 1 week prior (T0), 1 day after (T1), and 6 months after amyloid PET disclosure (T2). Questionnaires addressed patient‐reported experiences and outcomes. RESULTS Independent of amyloid status, participants were satisfied with the consultation (scale 1–10; 7.9 ± 1.7) and information provided (scale 1–4; T1: 3.3 ± 0.9, T2: 3.2 ± 0.8). After 6 months, A+ participants reported more information needs (45% vs. 12%, p = 0.02). Independent of amyloid status, decision regret (scale 1–5; A+: 1.5 ± 0.9, A−: 1.4 ± 0.6, p = 0.53) and negative emotions (negative affect, uncertainty, anxiety) were low (all p > 0.15 and P interaction > 0.60). DISCUSSION Participants with SCD valued amyloid PET disclosure positively, regardless of amyloid status. The need for information after 6 months, which was stronger in A+ individuals, underscores the importance of follow‐up. Highlights Participants with subjective cognitive decline (SCD) positively valued amyloid positron emission tomography (PET) disclosure. Participants with SCD experienced low levels of decision regret. We did not observe an increase in negative emotions. After 6 months, amyloid‐positive individuals wanted more information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Alzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
- Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.
- Medical Psychology, Amsterdam UMC location AMC, University of Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Public Health, Quality of Care, Personalized Medicine, Amsterdam, the Netherlands.
- Department of Radiology & Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
- Amsterdam Neuroscience, Brain Imaging, Amsterdam, the Netherlands.
ORCID-Profile: Heleen M A Hendriksen
Förderung
- Health∼Holland, Topsector Life Sciences & Health
- Horizon Europe IHI project PROMINENT
- ZonMw
Zitieren
APA
Hendriksen, H. M. A., de Rijke, T. J., Fruijtier, A., van de Giessen, E., van Harten, A. C., van Leeuwenstijn-Koopman, M. S. S. A., van der Schaar, J., Trieu, C., Visser, D., Smets, E. M. A., Visser, L. N. C., & van der Flier, W. M. (2024). Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14148
Vancouver
Hendriksen HMA, de Rijke TJ, Fruijtier A, van de Giessen E, van Harten AC, van Leeuwenstijn-Koopman MSSA, et al. Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14148
BibTeX
@article{Hendriksen2024,
author = {Hendriksen, Heleen M A and de Rijke, Tanja J and Fruijtier, Agnetha and van de Giessen, Elsmarieke and van Harten, Argonde C and van Leeuwenstijn-Koopman, Mardou S S A and van der Schaar, Jetske and Trieu, Calvin and Visser, Denise and Smets, Ellen M A and Visser, Leonie N C and van der Flier, Wiesje M},
title = {Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.14148}
}
EUVIMED